Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04783558 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 5, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: May 30, 2025 to Sep 30, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jun 30, 2025 to Sep 30, 2026
    • Site details revised
    v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 1, 2024 to Jul 15, 2024
    • Site details revised
    v5
  3. Start date: Feb 28, 2024 to Jun 1, 2024
    • Primary completion date: Mar 31, 2025 to May 30, 2025
    v4
  4. Start date: Sep 30, 2023 to Feb 28, 2024v3
  5. Primary completion date: Sep 2024 to Mar 31, 2025
    • Start date: Sep 2022 to Sep 30, 2023
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Most newborns experiencing Neonatal Abstinence Syndrome (NAS) require non-pharmacologic care, which entails, most importantly, maternal involvement with her newborn. To facilitate positive maternal-newborn interactions, mothers need to learn effective caregiving NAS strategies while they are pregnant, yet, an enormous gap exists in the early education of mothers on the symptoms and progression of NAS, in part because no interventions exist to prepare future mothers for the challenges of caring for their newborns at risk for NAS. In this project, the investigators propose to adapt an existing mobile NAS tool for high-risk pregnant women and assess its usability, acceptability, and feasibility in a small randomized controlled analog trial.
Trial Details
NCT Number NCT04783558
Lead Sponsor Washington State University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 Neonatal Abstinence Syndrome, Opioid-use Disorder
Related terms Neonatal Abstinence Syndrome, Opioid-Related Disorders
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov